These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 17882719)
41. Mobilization, collection, and transplantation of peripheral blood hematopoietic progenitor cells in a patient with multiple myeloma and hemoglobin SC disease. Tormey CA; Snyder EL; Cooper DL Transfusion; 2008 Sep; 48(9):1930-3. PubMed ID: 18513256 [TBL] [Abstract][Full Text] [Related]
42. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma. Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425 [TBL] [Abstract][Full Text] [Related]
43. No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Di Campli C; Piscaglia AC; Giuliante F; Rutella S; Bonanno G; Zocco MA; Ardito F; Nuzzo G; Mancuso S; Leone G; Gasbarrini G; Pola P; Gasbarrini A Transplant Proc; 2005; 37(6):2563-6. PubMed ID: 16182744 [TBL] [Abstract][Full Text] [Related]
44. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts. Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769 [TBL] [Abstract][Full Text] [Related]
49. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma. Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991 [TBL] [Abstract][Full Text] [Related]
50. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity. Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766 [TBL] [Abstract][Full Text] [Related]
54. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation. Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260 [TBL] [Abstract][Full Text] [Related]
55. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation. Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793 [TBL] [Abstract][Full Text] [Related]
56. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin. Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434 [TBL] [Abstract][Full Text] [Related]
57. Peripheral blood stem cell mobilization with pegfilgrastim compared to filgrastim in children and young adults with malignancies. Fritsch P; Schwinger W; Schwantzer G; Lackner H; Sovinz P; Wendelin G; Benesch M; Sipurzynski S; Urban C Pediatr Blood Cancer; 2010 Jan; 54(1):134-7. PubMed ID: 19785023 [TBL] [Abstract][Full Text] [Related]
58. Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma. Perea G; Sureda A; Martino R; Altés A; Martínez C; Cabezudo E; Amill B; Martín-Henao GA; González Y; Muñoz L; Peyret M; Brunet S; Sierra J Ann Hematol; 2001 Oct; 80(10):592-7. PubMed ID: 11732870 [TBL] [Abstract][Full Text] [Related]
59. Collection of peripheral blood progenitor cells: analysis of factors predicting the yields. Lee JL; Kim SB; Lee GW; Ryu MH; Kim EK; Kim S; Kim WK; Lee JS; Suh C Transfus Apher Sci; 2003 Aug; 29(1):29-37. PubMed ID: 12877890 [TBL] [Abstract][Full Text] [Related]
60. Pegfilgrastim for peripheral CD34+ mobilization in patients with solid tumours. Willis F; Woll P; Theti D; Jamali H; Bacon P; Baker N; Pettengell R Bone Marrow Transplant; 2009 Jun; 43(12):927-34. PubMed ID: 19169289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]